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ABSTRACT
Kleefstra syndrome, a disease with intellectual dis-
ability, autism spectrum disorders and other de-
velopmental defects is caused in humans by hap-
loinsufficiency of EHMT1. Although EHMT1 and its
paralog EHMT2 were shown to be histone methyl-
transferases responsible for deposition of the di-
methylated H3K9 (H3K9me2), the exact nature of
epigenetic dysfunctions in Kleefstra syndrome re-
mains unknown. Here, we found that the epigenome
of Ehmt1+/− adult mouse brain displays a marked in-
crease of H3K9me2/3 which correlates with impaired
expression of protocadherins, master regulators of
neuronal diversity. Increased H3K9me3 was present
already at birth, indicating that aberrant methyla-
tion patterns are established during embryogenesis.
Interestingly, we found that Ehmt2+/− mice do not
present neither the marked increase of H3K9me2/3
nor the cognitive deficits found in Ehmt1+/− mice, in-
dicating an evolutionary diversification of functions.
Our finding of increased H3K9me3 in Ehmt1+/− mice
is the first one supporting the notion that EHMT1 can
quench the deposition of tri-methylation by other Hi-
stone methyltransferases, ultimately leading to im-
paired neurocognitive functioning. Our insights into
the epigenetic pathophysiology of Kleefstra syn-
drome may offer guidance for future developments
of therapeutic strategies for this disease.
INTRODUCTION
Disruption of epigenetic marks has been frequently impli-
cated in the pathophysiology of cognitive disorders and in-
tellectual disability (1,2). Kleefstra syndrome, caused by
haploinsufficiency ofEHMT1, is characterized by severe in-
tellectual disability (ID), autism spectrum disorders (ASD),
developmental delay, childhood hypotonia and craniofa-
cial abnormalities (3,4).EHMT1 and its closely related par-
alog EHMT2 are histone methyltransferases primary re-
sponsible for deposition at euchromatic DNA of the di-
methylated H3K9 (H3K9me2) (5–9). H3K9me2 and es-
pecially H3K9me3, which is produced by the addition a
third methyl group to H3K9me2, are repressive marks that
are non-permissive for transcription. Many of the human
clinical features of Kleefstra syndrome are recapitulated
in mice carrying constitutive haploinsufficiency of Ehmt1
(Ehmt1+/−), making it a highly valid mammalian model
(10–12) for the human counterpart. Recently, first insights
into the molecular pathophysiology of Kleefstra syndrome
have been obtained. For instance, the cranial abnormalities
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were associated to a reduction ofH3K9me2 and consequent
UP-regulation of bone morphogenetic genes (12).
Furthermore, EHMT1 deficiency was associated with
impaired synaptic scaling, a mechanism that maintains
neuronal network activity homeostasis (13), delayed neu-
ronal network development (14) and compromised neu-
ronal identity (15). Given the many reports linking Ehmt1
or Ehmt2 complete knock-outs to loss of H3K9me2 and
consequent up-regulation of gene expression (5,16–19), im-
paired H3K9me2/3 is suspected to be the main cause of
the Kleefstra syndrome. However, no quantitative genome-
wide studies have yet been reported for constitutive hap-
loinsufficency of Ehmt1 and for this reason the epigenetic
dysfunctions causing impaired brain development andmen-
tal retardation in Kleefstra patients are still largely un-
known. Furthermore, EHMT1 and EHMT2 reside in com-
mon complexes (6), but it is unclear whether also haploin-
sufficiency of EHMT2 could result in a Kleefstra-like syn-
drome.
MATERIALS AND METHODS
Mutant mouse lines
The Ehmt1+/− heterozygous knockout mice were obtained
from Dr Shinkai and Dr Tachibana (Kyoto University,
Japan (5)). Ehmt1+/− heterozygous knockout mice were
genotyped and characterized (protein level) in previous
works (10–12). The Ehmt2+/− heterozygous knockout mice
were obtained fromDr Feil (Institute ofMolecular genetics
atMontellier, France (20,21)). EHMT2 knockout efficiency
and specificity was confirmed by RNA-sequencing (–44%,
RNAseq, Supplementary Figure S8A) and western blotting
(–78%, Supplementary Figure S8B).
Phenotyping
Animals. A cohort of 8 wt, 8 Ehmt1+/− and 8 Ehmt2+/−,
mutant male mice bred at the Celphedia-ICS were used
for behavioural phenotyping. They had mix genetic back-
ground (B6N*B6J 75/25) and were group housed (2–4 per
cage) and allowed 2 weeks acclimation in the phenotyping
area with controlled temperature (21–22◦C) under a 12–12
h light–dark cycle (light on at 07 a.m.), with food and water
available ad libitum. Behavioral testing started at 10-week-
old and was carried out in agreement with the EC directive
2010/63/UE86/609/CEE andwith the agreement of the lo-
cal Ethics committee under the license number 2012–139.
Gross neurological examination. The general health and
basic sensory motor functions were evaluated using a mod-
ified SHIRPA protocol (EMPRESS, eumorphia.org). This
analysis provides an overview of physical appearance, body
weight, body temperature, neurological reflexes and sensory
abilities.
Rotarod test. This test measures the ability of an animal
to maintain balance on a rotating rod (Bioseb, Chaville,
France). Mice were given three testing trials during which
the rotation speed accelerated from 4 to 40 rpm in 5 min.
Trials were separated by 10–15 min interval. The average
latency was used as index of motor coordination perfor-
mance.
Grip test. This test measures the maximal muscle strength
(g) using an isometric dynamometer connected to a grid
(Bioseb). Each mouse was submitted to three consecutive
trials immediately after the modified SHIRPA procedure.
Once the animal was holding the grid with its all paws it
was slowly moved backwards until it released it.
Hot plate test. The mice were placed into a glass cylinder
on a hot plate adjusted to 52◦C (Bioseb). The latency of
the first reaction (licking, flinches, . . . ) was recorded, with
a maximum of 30 s.
Shock threshold test. The mouse is placed in the fear-
conditioning chamber and allowed to habituate for 30 s.
Foot-shock is then manually applied for 1 s, and behav-
ioral responses noted. Shock levels began at 0.05 mA, and
increased in 0.05 mA steps with 30 s interval between the
shocks, until both flinch (any detectable response) and vo-
calization are induced. After this point, shocks were in-
creased in 0.1 mA steps until a jump (the mouse flinches
such that the two hind paws leave the ground) is induced. A
1 mA cut-off is employed in this test.
Circadian activity. Spontaneous locomotor activity and
rears were measured using 24 individual boxes equipped
with infra-red captors. The quantity of water and food
consumed was measured during the test period using au-
tomated pellet feeder and lickometer (Imetronic, Pessac,
France). Mice were tested for 35 h in order to measure ha-
bituation to the apparatus as well as nocturnal and diurnal
activities. Results are expressed per 1 h periods.
The open field test. Mice were tested in automated open
fields (Panlab, Barcelona, Spain), each virtually divided into
central and peripheral regions. The open fields were placed
in a room homogeneously illuminated at 70 lx. Each mouse
was placed in the periphery of the open field and allowed
to explore freely the apparatus for 30 min, with the experi-
menter out of the animal’s sight. The distance traveled, the
number of rears, and time spent in the central and periph-
eral regions were recorded over the test session. The number
of entries and the percentage of time spent in center area are
used as index of emotionality/anxiety.
Elevated plus maze. The apparatus used was completely
automated andmade of PVC (Imetronic, Pessac, France). It
consisted of two open arms (30× 5 cm) opposite one to the
other and crossed by two enclosed arms (30 × 5 × 15 cm).
The apparatus was equipped with infrared captors allowing
the detection of the mouse in the enclosed arms and differ-
ent areas of the open arms. The number of entries into and
time spent in the open arms were used as an index of anx-
iety. Closed arm entries were used as measures of general
motor activity. Ethological parameters such as stretching,
attempts and head dips, were also automatically scored.
Social recognition. This task is used to evaluate the pref-
erence of a mouse for a congener as compared to an ob-
ject placed in an opposite compartment. Reduced social be-
haviour is observed in psychiatric disorders and mental re-
tardation. The apparatus is composed with a central start-
ing box and two goal boxes. In each goal box, a grid cup
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is positioned and in an object or a congener is placed dur-
ing testing. Testing was performed for two consecutive days.
On the first day, fresh bedding was placed in the goal boxes.
The mouse was placed in start box for 30 s then allowed to
explore freely the apparatus for 10 min in order to atten-
uate their emotionality and to evaluate any potential pref-
erence between the two compartments. On the second day,
mice were tested for social preference (social recognition). A
C57Bl/6 congener from the same gender was placed in one
goal box and an object (dice for example) placed in the op-
posite one. The mouse was then placed in the start box for
30 s then allowed to explore freely the apparatus for 10 min.
The position of the congener and object boxes was coun-
terbalanced to avoid any potential spatial preference. Mice
were then tested for evaluation social memory. A third trial
(10 min-duration) is performed immediately after evalua-
tion of the preference for congener/object. The congener
(familiar) is remained in the same goal box and a new con-
gener is placed in the other goal box (where the object was
previously placed). The mouse to be tested is then placed in
the start box (central box) for 30 s then allowed to explore
freely the apparatus for 10min. The duration of exploration
of each goal box (when the mouse is sniffing the grid delim-
iting the goal box) was measured. The percentage of time
themouse takes to explore the congener versus object or the
novel versus familiar congener were used as index of social
preference (recognition preference) and social memory. The
number of entries and the time spent in each goal box, and
vertical activity in each box were also measured. A social
recognition index (SR) is defined as (time Congener/(time
Object + time Congener)) × 100. A social memory index is
defined as (time Novel Congener/(time Novel Congener +
time Familiar Congener)) × 100.
Auditory startle reflex reactivity and Pre-Pulse inhibition.
Acoustic startle reactivity and pre-pulse inhibition of star-
tle were assessed in a single session using standard startle
chambers (SR-Lab Startle Response System, San Diego In-
struments, USA). Ten different trial type were used: acous-
tic startle pulse alone (110-db), eight different prepulse trials
in which either 70, 75, 85 or 90-dB stimuli were presented
alone or preceded the pulse, and finally one trial (NOSTIM)
in which only the background noise (65 dB) was presented
to measure the baseline movement in the Plexiglas cylinder.
In the startle pulse or prepulse alone trials, the startle reac-
tivity was analyzed and in the prepulse plus startle trials the
amount of PPI was measured and expressed as percentage
of the basal startle response.
Object recognition task. The object recognition task was
performed in automated open fields (see above). The open-
fields were placed in a room homogeneously illuminated at
70 lx at the level of each open field. The objects to be dis-
criminatedwere a glassmarble (2.5 cmdiameter) and a plas-
tic dice (2 cm). Animals were first habituated to the open-
field for 30 min. The next day, they were submitted to a 10-
min acquisition trial during which they were placed in the
open-field in presence of an object A (marble or dice). The
time the animal took to explore the object A (when the ani-
mal’s snout was directed towards the object at a distance ≤
1 cm) is manually recorded. A 10-min retention trial is per-
formed 3 h later. During this trial, the object A and another
object B are placed in the open-field, and the times tA and
tB the animal takes to explore the two objects are recorded.
A recognition index (RI) is defined as (tB/(tA + tB))× 100.
Y-maze spontaneous alternation. The apparatus was a Y-
maze made of Plexiglas and having 3 identical arms (40
× 9 × 16 cm) placed at 120◦ from each other. Each arm
had walls with specific motifs allowing distinguish it from
the others. Each mouse was placed at the end of one of
the three arms, and allowed to explore freely the apparatus
for 5min, with the experimenter out of the animal’s sight.
Alternations are operationally defined as successive entries
into each of the three arms as on overlapping triplet sets
(i.e. ABC, BCA . . . ). The percentage of spontaneous alter-
nation was calculated as index of working memory perfor-
mance. Total arm entries and the latency to exit the starting
arm were also scored as indexes of ambulatory activity and
emotionality in the Y-maze, respectively.
The pavlovian fear conditioning. Polymodal operant cham-
bers (Coulbourn Instruments, Allentown, PA, USA) were
used. Each chamber (18.5× 18× 21.5 cm) consisted of alu-
minum side walls and Plexiglas rear and front (the door)
walls. A loudspeaker and a bright light constituted the
sources of the cues during conditioning and cue-testing. The
general activity of animals was recorded through the in-
frared cell placed at the ceiling of the chambers and was
directly recorded on a PC computer using theGraphic State
software (Coulbourn). For conditioning, mice were allowed
to acclimate for 4 min, then a light/tone (10 kHz) CS was
presented for 20 s and co-terminated by a mild (1 s, 0.4 mA)
footshock (US). Mice were returned to their home cages 2
min later. Testing was performed 24 h following condition-
ing session. Testing for the context was performed in the
morning. The mouse was placed back into the same cham-
ber that was used for the conditioning and allowed to ex-
plore for 6 min without presentation of the light/auditory
CS. Testing for the cue was performed in the afternoon
(∼5 h after the context testing). The contextual environ-
ment of the chambers was changed (wall color, odor and
floor texture). The mouse was placed in the new chamber
and allowed to habituate for 2 minutes then presented with
light/auditory cues for 2 min. This sequence was repeated
once again. At the end of testing, animals were returned to
their home cages.
Statistical analysis. Data were analyzed using unpaired
Student’s t-test or repeated measures analysis of variance
(ANOVA) with one between factors (genotype) and one
within factor (time). A Student-Neumann–Keuls post hoc
analysis was used to compare data between each two
groups. Additional one group t-test or paired t-test were
used to compare performance to the chance level or be-
tween two conditions in the same group (e.g. familiar vs
novel congener). Qualitative parameters (e.g. clinical obser-
vations, susceptibility to seizures) were analyzed using  2
test. The level of significance was set at P < 0.05.
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RNA-seq and ChIP-seq libraries
Tissue samples were dissected and snap-frozen in liquid
nitrogen. Next, samples were grinded in a liquid-nitrogen
chilled mortar and the resulting powder was split into mul-
tiple aliquots: for RNA extraction and ChIP. Total RNA
was Trizol extracted and RNA was treated with DNase
(Qiagen, Venlo, The Netherlands) and purified on the
RNeasy MinElute Cleanup Kit (Qiagen). 2000 ng of total
RNA were treated with the Ribo-Zero rRNA Removal Kit
(Human/Mouse/Rat; Illumina MRZH11124, Eindhoven,
The Netherlands). Depleted RNA was precipitated 1hr at -
80C in three volumes of ethanol plus 1ug of glycogen. RNA
was then washed and resuspended in 36 ul of Rnase free
water. RNA fragmentation buffer (NEBNext®Magnesium
RNA Fragmentation Module, NEB, Leiden, The Nether-
lands) was added to the solution and the RNA was frag-
mented by incubation at 95◦C for 3 min. Reverse transcrip-
tion: cDNA first strand synthesis was performed with ran-
dom hexamer primers. cDNA second strand synthesis was
performed with dUNTPs, to ensure strand specificity. The
RNA-seq library was synthesized with KAPA Hyper prep
kit (Kapa Biosystems,Wilmington,MA,USA): a treatment
with USER enzyme (NEB, M5505L) was added to digest
the unspecific strand.
ChIP-seq samples were prepared following the
standardized Blueprint-IHEC (international human
epigenome consortium) protocols and antibodies
(http://www.blueprint-epigenome.eu/UserFiles/File/
Protocols/Histone ChIP May2013.pdf): H3K27ac (Di-
agenode pAb-196-050), H3K4me3 (Diagenode pAb-003-
050), H3K4me1 (Diagenode pAb-037-050), H3K27me3
(Diagenode pAb-195-050), H3K9me3 (Diagenode pAb-
193-050), H3K36me3 (Diagenode pAb-192-050) or
H3K9me2 (Abcam ab1220).
Briefly, the tissue power of the ChIP aliquot was fixed
with 1% formaldehyde (Sigma) in a rotating 1.5 ml Eppen-
dorf at room temperature for 5 min. Fixed tissue prepara-
tions were sonicated using a Diagenode Bioruptor UCD-
300 for 4 min (30 s on; 30 s off). Next, 67 l of chro-
matin were incubated overnight at 4◦C with rotation with
229 l dilution buffer, 3 l protease inhibitor cocktail and
0.5–1 g of H3K27ac, H3K4me3, H3K4me1, H3K27me3,
H3K9me3, H3K36me3 or H3K9me2 antibodies. Protein
A/G magnetic beads (Dynabeads™ Invitrogen, 10008D,
10009D) were washed in dilution buffer with 0.15% SDS
and 0.1% BSA, added to the chromatin/antibody mix and
rotated for 60 min at 4◦C. Beads were washed with 400 l
buffer for 5 min at 4◦C with five rounds of washes. After
washing chromatin was eluted using elution buffer for 20
min. Supernatant was collected, 8 l 5M NaCl, 3l pro-
teinase K were added and samples were incubated for 4 h
at 65◦C. Finally, samples were purified using QIAGEN; Qi-
aquick MinElute PCR purification Kit and eluted in 20 l
EB. ChIP-seq libraries were synthesized with KAPAHyper
prep kit (Kapa Biosystems, KK8504) following the manu-
facturer’s instructions. The libraries were pooled (4/lane)
and sequenced on the Illumina HiSeq 2000. RNA-seq li-
braries were mapped with GSNAP (22) (version 2015-06-
23, RefSeq annotations) and ChIP-seq libraries with BWA
(23) (0.6.2), genome build mm9.
GO enrichments
GO annotations are updated to 25/6/2015. Enrichments
are made with hypergeometric test, bonferroni corrected.
DNA bisulfate sequencing
DNA was isolated using the Cell Culture DNA Midi
Kit from QIAGEN (Cat No 13343) or GenElute™ Mam-
malian Genomic DNA Miniprep Kit (Cat No. G1N350,
Sigma). BS-seq was performed as described previously (Lis-
ter et al., 2008). FASTQ sequence files generate for BS-seq
were aligned toMusmusculusNCBIM37 genome assembly
(mm9) using rmapbs-pe (https://github.com/smithlabcode/
rmap) allowing a maximum of 10 mismatches for efficient
mapping of reads containing bisulfite converted unmethy-
lated cytosines. 5mC level were directly determined using
MethPipe (24). In short, both mates of the paired-end
sequencing were mapped separately by RMAPBS. Reads
mapping equally well on multiple positions on the genome
were excluded from further analysis. Mates mapping within
amaximum distance of 500 bp weremerged and other reads
were excluded from further analysis. If multiple mated reads
mapped on exactly the same genomic coordinates (dupli-
cates), all but one were discarded. Within a CpG context,
symmetric cytosines on both forward and reverse strands
were combined. Cytosine methylation level was called per
individual C as #C/(#C + #T). For WGBS a CpG cover-
age threshold of ≥10 was used.
Quantitative RT-qPCR––MIQE guidelines essential infor-
mation
Experimental design: Three wild type P30 hippocampi, 3
Ehmt1+/– hippocampi, H3K4me3 ChIP sample.
Sample: H3K4me3 ChIP sample, stored at –80◦C.
qPCR target information: genomic amplicon, details be-
low.
Length
Amplicon
length
Melting
temp. gc% seq
Pcdhb5 LEFT
PRIMER
20 86 60.69 50 TGCTTCCTGGTC
CTTTGTGT
RIGHT
PRIMER
20 86 60.93 50 CCCATTCAAGGT
CGGGTATT
Pcdhb14 LEFT
PRIMER
20 100 60.1 50 GCAAGTGACCGC
CATTATCT
RIGHT
PRIMER
19 100 60.24 57.89 CACCAAAGAGCC
CCTGTCT
Pcdhb15 LEFT
PRIMER
19 108 59.78 63.16 GGCACCCCTCTC
TTCTCAC
RIGHT
PRIMER
21 108 59.66 42.86 CCCCAAATTCCT
TCCATTTAG
Pcdhb22 LEFT
PRIMER
21 80 60.01 47.62 GGTGCAGAAG
CAAAGATGAAG
RIGHT
PRIMER
20 80 59.84 50 ACCACTCCCAGC
AAGAGAAA
qPCR protocol: Reaction volume 25 ul composed of
10.9 ul nuclease free (NF) water, 0.5 ul primers, 1.1 ul ChIP
sample in NF water, 12.5 ul IQ Sybr Supermix (Biorad
#1708884). Cycles: 1×) 95◦C, 3min 40×) 95◦C10 s, 58◦C40
smelting curve) 58–95◦C, increment 0.5◦C, 5 s. Optical head
serial number: 785BR8460. Base serial number: CT004082.
CFXManager version: 3.0.1224.1015.
qPCR validation and DATA Analysis: Biorad CFX
Manager version 3.0.1224.1015. Justification of number
and choice of reference genes: not applicable. Two techni-
cal replicates (wells) for each sample. For other information
see Supplementary Figure S6B.
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Peak calling
Peak calling was performed for H3K4me1/2,
H3K27ac/me3, H3K36me3 and H3K9me3 as follows.
The 25% of the mappable genome with the lowest
nonzero coverage was estimated as the background level.
Next, regions displaying a signal higher than two times
the background for at least 300 kb were considered
as peaks. Peaks called from multiple samples of the
same histone mark were than merged. Merged peaks
and normalized tags counts are available in GEO. The
code used for peak calling has been deposited in github
https://github.com/iaconogi/Histone-mark-analysis.
Data normalization and DEseq2
Significant changes in expression or histonemarks were cal-
culated as follows. Initially, the uniquely mapped tags were
counted in a given annotation list. Annotations used were
(i) refseq mm9 genes for RNA-seq (exon data only), (ii)
refseq mm9 gene bodies for H3K36me3, (iii) refseq mm9
gene promoters (TSS± 2 kb) for H3K9me2/3, H3K27me3,
H3K4me1 and DNA methylation. (iv) Previously called
peaks forH3K4me3, H3K27ac. Next, tags counts were nor-
malized to account for library size (geometric mean) and P-
values were calculated in DEseq2, which estimates the like-
lihood of a change by means of a negative binomial distri-
bution.
Analysis of RNAseq and H3K4me3 in postnatal development
Genes displaying a significant (P < 0.01) change in ex-
pression (RNAseq) or H3K4me3 (promoter) in at least
one developmental stage were considered deregulated in
Ehmt1+/− mice as opposed to wild type mice. This resulted
into 255 genes. Next, wild type samples of postnatal (P1, P7,
P15, P30, RNAseq and H3K4me3) stages were analyzed in
order to define the genes changing expression in the course
of wild-type development. Criteria for significant changes:
max (FCi)> 2, min (Pvali)<2.9e–07, i= 1:C(n,k), where
FC represent the fold change, Pval the P-value, n= 4 as the
number of developmental stages, k = 2 and i as the cou-
ples of developmental stages. In other terms, pair wise com-
parison of expression are performed for all the 12 possible
couples of developmental stages (as for example P1/P30 or
P7/P15). A gene is considered significantly changed if it dis-
plays in at least one of these comparison a change of ex-
pression (RNAseq or H3K4me3) which is at least 2-fold
and P < 2.9e–07 (equivalent to a Z-score of 5). Threshold
for P-value is very stringent because postnatal transcrip-
tome undergoes extensive changes and we aim to select the
main developmental markers. Next, all genes were collected
in four different expression patterns: UP, DN, STABLE,
OTHERS. Given X as the expression value, genes in which
XP15 > XP1, XP30 > XP1, XP7 < XP15 are classified as up-
regulated. Opposite for DN-regulated. STABLE genes do
not change expression, as they do not satisfy the criteria for
significant changes. OTHERS change expression, as they
satisfy the criteria, but with transient variations which are
neither UP nor DN.
Sliding window analysis of H3K9me2, H3K9me3 and
H3K27me3 ChIP-seq
The genome wide analysis of repressive marks H3K9me2,
H3K9me3 and H3K27me3 were based on a sliding win-
dow approach. As a first step, genome is divided in over-
lapping bins of 5 kb starting every 1.5 kb. In this way, each
bin overlaps of 3.5 kb with his neighbors. For the mouse
mm9 genome, the total amount of bins is 1 817 079. Subse-
quently, ChIP-seq tags are counted for every bin and the re-
sulting tag counts is given as input to DEseq2, an algorithm
based on the negative binomial distribution which identi-
fies the bins presenting a significant change in the number
of tags among two different conditions (for example, wild
type and Ehmt1+/− hippocampus). Raw results of DEseq2
consist of a list of all the bins with significant changes. We
next transformed the lists of bins in lists of regions. To this
end, whenever two overlapping bins are called as significant
by DEseq2 we merged them. This procedure is iteratively
repeated until all the overlapping bins are merged. In this
way, when a change of H3K9me3 affects a broad region,
we recreate the area by merging all the individually deregu-
lated bins. Likewise, a circumscribed change of methylation
within a narrow region is detected with a single bin. There-
fore, this approach is very flexible, as it allows to isolate at
the same time both broad and local changes.
Ehmt1/Ehmt2 comparison of D-scores
Genes with D-scoreehmt1 > 6, D-scoreehmt2 < 6 are consid-
ered as up-regulated specifically in Ehmt1+/−. Otherwise
(D-scoreehmt1 > 6, D-scoreehmt2 > 6) they are considered
as commonly up-regulated. Same reasoning goes for down-
regulated genes and Ehmt2+/− specific deregulations. The
genes of the six regions of the Venn diagrams are ranked in
the Supplementary Table S1 (GEO).
GEO (gene expression omnibus data)
Data deposited in GEO, ID GSE89010. Elaborated data
uploaded in GEO includes: D-scores for P30 Ehmt1 and
Ehmt2 epigenomes, developmental Ehmt1 clusters, P30
Ehmt1 deregulated genes clusters, Ehmt1 vs Ehmt2 gene
sets, Raw reads counts for RNAseq samples, Peak calls and
raw reads counts for H3K4me1, H3K4me3, H3K36me3,
H3K27ac, H3K9me3, H3K27me3.
Clustering
Clustering of ChIP-seq regions and developmental
RNAseq/H3K4me3 data was achieved by means of a
three-step, semi-supervised algorithm consisting of ‘tra-
jectory clustering’ (1st step, to find the optimal number of
clusters), ‘k-means, sq-euclidean distance’ (second step, to
create fine-graded clusters) and an optional ‘parametric
clustering’ (third and last step, to merge fine-graded clusters
in final clusters). Given a input matrix m*n of expression
values which needs to be clustered, ‘trajectory clustering’
simplifies the values of the input matrix such that each
original value is reduced to only five possible values de-
limited by the 10th, 30th, 70th and 90th percentiles. These
five values can be generally interpreted as ‘not changed’,
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‘up(down)-regulated’, ‘strongly up(down)-regulated’ or,
equally, ‘medium’, ‘above(below)-average’, ‘ strongly
above(below)-average’. Subsequently, each element is
associated with a trajectory (a unique tuple of these five
values) and the trajectories collecting enough elements
are recognized as the real/main trajectories. The minimal
number of elements that a real trajectory must collect is set
with the parametermin el. Here, we generally used very low
min el in order to retain as many trajectories as possible,
to minimize loss of information. More precisely, min el
was set to 0.1%, meaning that a trajectory is considered as
real if it collects at least 0.1% of the total elements to be
clustered. The final number of real trajectories is equivalent
to the optimal number of clusters. Once determined the
optimal amount of clusters, the m*n matrix (with its
original values) is then clustered via standard k-means with
squared Euclidean distance. Given that a low min el was
used, the number of clusters generated via k-means was
generally very high, also ranging from 40 to 70 in most
cases. We refer to these clusters as fine-graded clustering.
When fine-graded clusters were too many, a parametric
model is generated with the aim to further collapse the
centroids and obtain the final clusters. A parametric model
establishes a rigid set of values (parameters) which allows
to pool the centroids sharing similar features. Centroids
which do not fit any of the parametric model are directly
retained as individual, final clusters. At this final step,
clusters which collect less than 1% of the total elements are
considered outliers and discarded. The parametric models
used in the manuscript are shown below
3RD STEP: PARAMETRIC CLUSTERING OF
BRAIN AREAS H3K9ME3 CENTROIDS (FC, frontal
cortex, OB olfactory bulb, H hippocampus, CE cerebellum)
3RD STEP: PARAMETRIC CLUSTERING OF
BRAIN Ehmt1+/− and Ehmt2+/− CENTROIDS
(H3K9me3 and H3K27me3)
RESULTS
Increased H3K9 di- and tri-methylation in the adult hip-
pocampus of Ehmt1+/− mice
To gain insight into the epigenetic changes associated with
haploinsufficiency of Ehmt1 or Ehmt2 in mice, a com-
prehensive epigenetic dataset (seven histone marks, DNA
methylation and RNAseq) encompassing 200 biological
samples of multiple brain areas and developmental stages
was generated according to the BLUEPRINT/IHEC stan-
dard (25) (Figure 1A). All ChIP-seq profiles show an excel-
lent enrichment of the signal over the background (Figure
1B).
We initially focused on the hippocampus, a crucial brain
structure for a multitude of cognitive functions. A genome
wide assessment of the epigenome of Ehmt1+/− (5) and
wild type adult (P30) hippocampus revealed that heterozy-
gous mice display extensive increase in H3K9me2 and
H3K9me3, with more restricted changes of the other his-
tonemarks (Figure 1C). Specifically, instead of the expected
decrease in H3K9 methylation, we found significantly
(P<0.001, DEseq2 (26)) increased levels of H3K9me3 in
Ehmt1+/− hippocampus in a total of 99.2 Mb (6009 re-
gions, 73% intergenic, 15% promoters, 12% gene bodies)
whereas only few regions (3.15 Mb, 587 regions) displayed
reduced H3K9me3 (Figure 2A and B). This result was val-
idated by the use of unbiased, non-parametric statistical
tests and t-sne (27) analysis, which resulted in a clear seg-
regation between heterozygous and wild type, as well as
high concordance between biological replicates (Figure 2B
andC). In the same regions displaying increasedH3K9me3,
H3K9me2 is increased too (Figure 2D).
One explanation that needed to be excluded is that the in-
creased H3K9me3 levels could have been artificially gener-
ated by the normalization. The use of alternative statistical
methods that are commonly used for library-normalization
showed that increased H3K9me3 is consistently detected
with significant P-values independently from the normal-
ization approach (Supplementary Figure S1A).
Moreover, genes displaying increased H3K9me3 at their
promoter also display reduced expression (RNA-seq), de-
creased active marking (H3K4me3, H3K4me1, H3K27ac,
H3K36me3) and increased repressive H3K9me2 and DNA
methylation (GWBS) (Figure 2E). These multiple, concor-
dant changes in epigenetic makeup and RNA expression
further support the notion that increase of H3K9me3 is not
an artifact. Increased H3K9me3 mostly localizes over long
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Figure 1. Overview of the epigenetic dataset. (A) Samples table indicating the number of mice used in each experiment (wild type/mutant). (B) Examples of
tracks. Y-axis: coverage is shown for ChIP-seq tracks.Methylation (0–1) is shown forDNAme track.Magnified plot for a region with increasedH3K9me3 is
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stretches (from 25 kb up to 190 kb, Supplementary Figure
S1B) silencing hundreds of genes belonging to large clus-
tered families such as olfactory receptors (731/1102, P <
1e–1000), taste receptors (23/65, P < 2.3e–08), pheromone
receptors (62/99, P < 1.5e–46) among others.
IncreasedH3K9 tri-methylation is conserved inmultiple brain
regions and developmental stages
We next sough to determine whether the observed increase
of H3K9me3 found in hippocampus is also present in
other brain regions. Analysis of wild type and Ehmt1+/−
H3K9me3 samples from frontal cortex, olfactory bulb and
cerebellum (20 samples, littermates) showed that increased
H3K9me3 was consistently found in all investigated brain
regions, whereas consistent down-regulation of H3K9me3
could not be detected (Supplementary Figure S2).
We next surmised that the observed increase of
H3K9me2/3 in Ehmt1+/− could be the consequence
of events occurring earlier in brain development. There-
fore, we asked whether and when H3K9me3 is increased
in earlier stages of postnatal hippocampal development
(P1-P30 developmental stages, 20 samples, littermates).
Interestingly, H3K9me3 appeared markedly higher in
Ehmt1+/− hippocampi in every developmental stage tested,
starting already from postnatal day 1 (Supplementary
Figure S3A and B), indicating that aberrant H3K9me3 is
deposited before birth at embryonic stage.
Given the remarkable extent of H3K9me3 up-regulation
in multiple brain areas and developmental stages (con-
served up-regulation in 51 Mb Supplementary Figure S1B
and C) and the minimal (0.02 Mb) down-regulation, we
assessed whether the expression of any of the known H3K9
(de)methyltransferases (namely Suv39h1/2, SetDB1/2,
Prdm2, Kdm4A-D) or (de)acetyltransferases are dereg-
ulated in Ehmt1+/− brain. Intriguingly, none of these
regulators appeared deregulated in any brain area or
developmental stage of our dataset (Supplementary Figure
S3C).
Ehmt2+/− mice present a mild increase of H3K9me3
Despite the large functional overlaps reported between
the paralogous genes Ehmt1 and Ehmt2 (5,7–9,15,18), to
date no GWAS study has yet found any ID patient with
mutations in Ehmt2. We therefore wanted to investigate
whether also Ehmt2+/− (20,21) mice show increased H3K9
methylation levels like Ehmt1+/− mice. Furthermore, given
that both Ehmt1 and Ehmt2 were linked to in vivo and
in vitro to tri-methylation of H3K27 (19,28,29), we de-
termined the regions displaying significant (P < 0.01)
deregulations in H3K9me3 or H3K27me3 in Ehmt1+/−
or Ehmt2+/− hippocampi (22 samples, littermates). As a
result, we found that in 15% of the regions H3K9me3
is up-regulated to nearly similar extent in Ehmt1+/− and
Ehmt2+/− (C1) whereas in the remaining regions up-
regulation in Ehmt2+/− is much weaker (44% of regions) or
totally absent (39%) (Figure 3). This indicates that increase
ofH3K9me3 occurs also inEhmt2+/− mice, but not with the
same strength and extension as detected in Ehmt1+/− mice
and hence only in a subset of regions. Alterations in the level
of H3K27me3 are highly marginal in both mutants, indi-
cating that this mark shows minimal to absent deregulation
(Figure 3). Overall, these results indicate that heterozygous
deletion of Ehmt2 causes an increased H3K9me3 which un-
derpins the findings with Ehmt1+/−. However, the increase
is weaker compared to Ehmt1+/-and less extensive, indicat-
ing that haploinsufficiency of Ehmt2 does not alter the epi-
genetic makeup as strongly as Ehmt1.
Ehmt1+/− mice display impaired expression of protocad-
herins
We next set out to unravel the molecular dysfunctions of
Ehmt1+/− brain by analyzing the epigenome (seven histone
marks, RNA-seq and DNA methylation) of adult (P30)
hippocampus at actively expressed genes. Integrated anal-
ysis of histone marks, RNA-seq and DNAmethylation (see
Supplementary Figure S4A) revealed 53 up-regulated and
160 down-regulated genes in Ehmt1+/− compared to wild
type. In the 53 up-regulated genes a very mild decrease
of the repressive mark H3K9me2 at promoters correlates
with a marked increase of the four activating marks (espe-
cially H3K4me3) and RNA expression levels (Supplemen-
tary Figure S4B). Vice versa, down-regulated genes gener-
ally display a marked increase of H3K9me2/3 and DNA
methylation at their promoters concomitantly with a de-
crease of active marks and RNA expression (Figure 4A,
Supplementary Figure S4B). GO (gene ontology) analy-
sis of the down-regulated genes revealed exclusively a sig-
nificantly enrichment in clustered Protocadherins (20/59,
P < 8.5e–33) whereas no enrichments were found for up-
regulated genes. Interestingly, we found that only mem-
bers of clustered Protocadherins (Pcdhs) genes (alpha, beta
and gamma families) are down-regulated, whereas non-
clustered Pcdhs genes are unaffected. Clustered Pcdhs are
a major family (59 members) belonging to cadherin super-
family and expressed primarily in the vertebrate nervous
system. Similarly to olfactory receptors, these Pcdhs are
clustered in the genome in order to allow combinatorial
and monoallelic expression which is fundamental for the
proper development of dendritic arbors (30,31). The abun-
dance of clustered Pcdhs among epigenetically repressed
genes in Ehmt1+/− represents an interesting finding and
prompted for a more detailed investigation. Analysis of
all clustered Pcdhs promoters (59) revealed that the acti-
vating marks H3K4me3, H3K27ac, H3K36me3 are glob-
ally decreased in Ehmt1+/− (84%, 90%, 90% of promot-
ers, respectively) whereas H3K9me2/3 is globally increased
(>90%, Figure 4B and C). Furthermore, besides hippocam-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
shown (mean± SEM). (C) Overview of genome-wide deregulations for histone marks. H3K4me3, H3K27ac, H3K36me3 and H3K4me1 peaks were called
and DEseq2 was used to detect significant deregulations (P < 0.01) in Ehmt1+/− animals as compared to wild type littermates. For the repressive marks,
generally distributed in extended stretches, a genome-wide sliding window analysis and DEseq2 were used to detect significant deregulations (P < 0.001,
see methods).
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Figure 2. Epigenetic profiling of Ehmt1+/− unveils extensive up-regulation of H3K9me3. (A) Examples of regions showing a significant increase of in-
tergenic H3K9me3 or unaltered H3K9me3 over Hoxa genes. Average H3K9me3 coverage ± SEM, P-values (DEseq2, see methods) and threshold for
up/down-regulations (P < 0.001 equal to Z-score = 3). ( B) Predominant H3K9me3 up-regulation in Ehmt1+/− as show by the dimensionally reduced
(t-sne) plots of deregulated regions where dot size is proportional to the average length (17 kb up, 5kb down). The clear segregation into two clouds
indicates reproducibility of deregulations. (C) Clustering of statistical likelihood in H3K9me3 up-regulated regions segregates Ehmt1+/− and wild type
samples (Kruskal–Wallis test, euclidean distance, hierarchical clustering with Ward’s linkage). (D) Distribution of repressive epigenetic marks in the 6009
regions with increased H3K9me3. While H3K9me3 and H3K9me2 are strongly shifted towards positive values, indicating up-regulation, H3K27me3 and
DNA methylation are centered on zero, indicating lack of correlation with H3K9me2/3. ( E) AU041133, the gene with the strongest epigenetic repression
in Ehmt1+/−. Promoter (H3K4me1/3/K27ac/me3/K9me3), gene body (H3K36me3/K9me2), CpG island (DNAme). DEseq2 P-values *P< 0.05, **P<
0.025, ***P < 0.01 (see Materials and Methods) Y-axis, normalized tags, mean ± SEM.
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Figure 3. Ehmt1+/− and Ehmt2+/− comparative analysis of repressive histone marks. (A) Clustering of the regions with significant (P < 0.001) H3K9me3
or H3K27me3 deregulations in Ehmt1+/− or Ehmt2+/− samples. Left: Pie chart size representing the size of each cluster in terms of base pairs covered,
genome-wide. Right: Centroids mean, 25th and 75th percentiles for clusters C1–4. For each cluster the total amount of regions and their total length (size
in base pairs) is indicated. Only in 15% of regions (C1) Ehmt2+/− displays an increase of H3K9me3 comparable to Ehmt1+/−. Changes in H3K27me3 are
negligible (C4, 2%). (B) Example of H3K9me3 tracks. Average +/- SEM of a region formed by elements of C1 and C2 and encompassing several olfactory
receptors (from Olfr697 to Olfr711, not shown).
pus, also frontal cortex, cerebellum and olfactory bulb show
decreased H3K4me3 at Pcdhs promoters (Supplementary
Figure S5A) indicating that multiple regions in Ehmt1+/−
brain suffer epigenetic silencing of Pcdhs. Notably, the top
down-regulated Pcdhs are not randomly scattered but in-
stead sequential ones (Figure 4H, Supplementary Figure
S6). In fact, down-regulation follows a graded pattern with
peaks of repression in specific groups, for instancePcdhb13–
16 in the beta cluster (Figure 4H). Ehmt1 and H3K9methy-
lation were already known to be important for stochastic
expression of olfactory receptors (18), and here we extend
its importance also to the clustered Pcdhs.
Deregulations of gene expression in Ehmt1+/− hippocampus
are detected already at postnatal day 1
Epigenetic analysis revealed that a relatively reduced (213)
set of specific genes is deregulated in adult (P30) Ehmt1+/–
hippocampus. However, EHMT1 protein was shown to be
10x more expressed at P4 as compared to P30, suggesting
a prominent role for EHMT1 in the early postnatal devel-
opment (11). Therefore, we set to quantitatively define the
interplay of EHMT1 with postnatal development by select-
ing the genes displaying a significant (P < 0.01) change in
expression (RNAseq) or H3k4me3 (promoter) in at least
one developmental stage (P1, P7, P15 or P30), which yielded
255 genes. Interestingly, most the genes deregulated at P30
appear deregulated already at P1 (Figure 4D and E), in-
dicating that deregulation is established during embryonic
stage, same as found for the H3K9me3 increase. Several
Pcdhs (19/71) are already repressed at P1, as for instance
Pcdhb14 (Figure 4F). This finding is highly relevant because
itmeans thatPcdhs expression is impaired during the synap-
togenesis and sprouting of dendrites, which can account for
the reduced dendritic arborizaton found in Ehmt1+/− brain
(15). Finally, of the 5549 genes found to be regulated during
wild-type hippocampus development (Supplementary Fig-
ure S5B), only 109/5549 (<2%, such as Zfp951 in Figure
4G) are deregulated in Ehmt1+/−, indicating that the in-
fluence of Ehmt1 in regulation of gene expression during
postnatal developing is limited and specific. This most likely
occurs because the majority (98.6%) of postnatally regu-
lated genes does not colocalize with the long stretches of
H3K9me3 which are deregulated in Ehmt1+/−.
Ehmt2+/− displays mild deregulations of gene expression
which are occluded by Ehmt1+/−
It is hitherto unknownwhether haploinsufficiency ofEhmt2
would result in aKleefstra-like phenotype aswithEmht1+/−
(10,11,12). To further test the similarities and dissimilari-
ties between Ehmt1 and Ehmt2 epigenomes, we compared
Ehmt1+/− andEhmt2+/− mutant epigenomes (seven histone
marks, RNA-seq and DNAmethylation) in P30 hippocam-
pus with a focus on deregulations of gene expression (see
Materials and Methods).
Comparative epigenetic analysis revealed that, in both
mutants, down-regulated genes outnumber up-regulated
genes (>3× Ehmt1+/−, >2× Ehmt2+/−), in agreement with
the observed increase in the repressive mark H3K9 methy-
lation. However, Ehmt1+/− displays a larger ensemble of
deregulated genes compared to Ehmt2+/− (227 versus 102).
In the up-regulated genes (Figure 5A), Ehmt1+/− and
Ehmt2+/− display a reduced intersection (10 genes, exam-
ple Tfip2, Figure 5B) and larger sets of specific genes (44
and 22 respectively). Interesting examples are Tdo2, an en-
zyme implicated in serotoninmetabolism,which is epigenet-
ically up-regulated only in Ehmt1+/− (Figure 5B, details in
Supplementary Figure S4A) and Glo1, a metabolic detox-
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Figure 4. Epigenetic profiling of Ehmt1+/− developmental and adult hippocampus. (A) Increase of H3K9 methylation and repression of expression. Box-
plot, mean± SEMand 99% confidence interval for the genes of down-regulated cluster 1. Other deregulated genes are shown in Supplementary Figure S4B.
(B) Epigenetic repression of protocadherins inEhmt1+/− hippocampus. Smoothed bin count, percentages represent number of promoters<0 (down) or>0
(up). (C) Pcdhs beta subfamily is the most affected (9/21, 42% are repressed), example of Pcdhb15 (mean ± SEM, *P < 0.05, **P < 0.025, ***P < 0.01).
(D) Analysis of postnatal development: 255 were found deregulated (P< 0.01). The genes were divided in 5 clusters according to the profile (see methods).
The biggest cluster, C1, is shown, mean+/-SEM, 99% confidence interval (additional clusters in Supplementary Figure S5C-F). For C1, Kruskal-Wallis
test rejects the hypothesis of different means, both in RNA-seq and H3k4me3, indicating stability of repression from P1 to P30. (E) Deregulated Ehmt1+/−
epigenomes are largely stable during development, implying that deregulations are established during embryogenesis. Stacked centroids of the five clusters
(C1–C5) transformed in|log2(kd/wt)| each weighted for its size. (F–G) Examples of Ehmt1+/− deregulated genes in development. Y-axis, number of tags,
normalized to P1, mean ± SEM. DEseq2 P-values (*P < 0.05, **P < 0.025, ***P < 0.01). (H) Overview of Pcdhs beta cluster, from Pcdhb1 to Pcdhb22,
red-colored proportionally to the average RNAseq and H3K4me3 down-regulation. Down-regulation has a clear spatial distribution, with Pcdhb1 and
Pcdhb14/15 being at the center of strongest repressed loci.
ification enzyme, which is epigenetically up-regulated only
in Ehmt2+/− (Figure 5B).
Vice versa, in down-regulated genes we found a larger
inclusion of the Ehmt2+/– ensemble into the Ehmt1+/–
ensemble, as 28 genes (60%) are down-regulated also in
Ehmt1+/– (Figure 5A). Commonly repressed genes include
a large amount of zinc finger proteins (>35%, >10-fold en-
richment, P < 1e–7, example Zfp951). In contrast, exten-
sive repression of Pcdhs is specific to Ehmt1+/– (22 genes,
>12-fold enrichment). These data indicate that haploin-
sufficiency of Ehmt2 causes milder deregulations of gene
expression compared to Ehmt2+/−, which is in agreement
with themilder H3K9me3 increase. Furthermore, several of
Ehmt2 deregulations are occluded byEhmt1+/−, supporting
the latter paralog as the primary one in brain development
and functioning.
Ehmt2+/− mice do not present the severe cognitive deficits
presented by Ehmt1+/− mice
Phenotyping of Ehmt1+/− have previously highlighted se-
vere developmental delay, hypoactivity and mental retar-
Downloaded from https://academic.oup.com/nar/article-abstract/46/10/4950/4937548
by Radboud University user
on 06 August 2018
Nucleic Acids Research, 2018, Vol. 46, No. 10 4961
Figure 5. Ehmt1+/− and Ehmt2+/− comparative analysis of deregulated genes. (A) Venn diagrams comparing Ehmt1+/− and Ehmt2+/− deregulated genes.
Diagrams are based onD-scores which take into account expression and epigenetic makeup (seeMaterials andMethods). (B)Most representative examples
(as ranked in Supplementary Table S1, GEO). Only deregulated marks are shown and D-scores of each gene is indicated for each mutant model (E1 =
Ehmt1+/−, E2 = Ehmt1+/-).
dation (10–12). However, phenotyping of Ehmt2+/– mice
have not been reported so far. Given that Ehmt1 and Ehmt2
work in heterodimeric complex and often display overlap-
ping, non-redundant functions (5,6), we compared the phe-
notypes of Ehmt1+/– and Ehmt2+/-mice using a broad pal-
let of tests to evaluate general health, cognitive and behav-
ioral features. Comprehensive phenotyping of Ehmt1+/−
and Ehmt2+/− mice (>20 behavioral and cognitive tests,
Figure 6A) revealed thatEhmt1+/− but notEhmt2+/- are hy-
poactive (circadian activity Figure 6B, exploration of open-
field Figure 6C, social behavior Figure 6D, habituation in
fear conditioning Figure 6F). Different tests found alter-
ation of learning and memory only in Ehmt1+/-mice, in-
cluding a significant reduction of object recognition index
(Figure 6E) and a significantly lower suppression of ac-
tivity than wild type mice during re-exposure to the same
context in the fear conditioning/context test (Figure 6F–
G). Impaired sensory motor gating (Supplementary Figure
S7D) was found in both mutants, for the 75 dB prepulse
for Ehmt2+/− mice and through the different prepulses for
Ehmt1+/− mice (significant for 90 dB). In social behavior,
both Ehmt1+/− and Ehmt2+/− mice showed normal social
preference but impairment of social memory (Supplemen-
tary Figure S7E,F).No other significant changes inmutants
as opposed to wild-types were found. These data indicate
that Ehmt1+/– but not Ehmt2+/− mice show impaired cog-
nitive abilities and hypoactive behavior.
DISCUSSION
We describe here the detailed epigenetic and phenotypic
characterization of the Kleefstra syndrome Ehmt1+/-mouse
models and of its paralog Ehmt2+/−. Unexpectedly, we de-
termined that constitutive haploinsufficiency of EHMT1
and, to a lower extent, EHMT2 results in increased H3K9
trimethylation in targeted genetic loci. An extensive num-
ber of biochemical studies have firmly established EHMT1
and -2 as methyltrasferases (28,32), and that complete
loss of either Ehmt1 or Ehmt2 leads to a reduction of
H3K9me2 (5,7–9,16–19) and also H3K9me3 (18). While
we did find changes in genes previously shown to be tar-
gets ofEHMT1/2 (i.e. olfactory receptors) (18,33), the over-
riding change we observed in our epigenomic profiling of
Ehmt1+/− brain was paradoxically increased and not de-
creased H3K9me3. Importantly, the biological material we
have analyzed is different from that in previous studies
in at least two ways: firstly, our mutation is constitutively
present throughout the development, unlike other models
inducing EHMT1 deficiency at postnatal stages only (15).
Secondly, we studied haploinsufficency, which in humans
causes Kleefstra syndrome, and not complete loss of Ehmt1
as in homozygous knockouts (5,15,16,19).
Interestingly, a previous study showed that homozygous
Ehmt2−/− embryos, but not heterozygous Ehmt2+/– em-
bryos present severe growth retardation, early lethality and
drastically reduced H3K9me2 (western blot Figure 3 (16)).
Likewise,Ehmt1−/− but notEhmt1+/− embryoswere shown
to present severe growth retardation and early lethality to
the same extent of Ehmt2−/− embryos (5). These evidences
suggest that the embryonic loss of H3K9me2 is not present
in heterozygous mutants, in agreement with the lack of a
global reduction of H3K9me2 in our heterozygous mice.
We envisage that compensatory effects took place during
development of Ehmt1 and Ehmt2 heterozygous embryos.
Specifically, while Ehmt1/Ehmt2 are the main H3K9me1/2
HMTs, they were reported to be inefficient in depositing
H3K9me3 (7,34–36). Yet, we unveiled a strong increase es-
pecially of H3K9me3 suggesting that other HMTs, possibly
Suv39H1/2 or SetDB1/2 are involved. Interestingly, it was
previously hypothesized that EHMT1/2 via their ankyrin
repeats bind to H3K9me1/2 quenching the deposition of
tri-methylation by other HMTs (7). Our novel data is com-
patible with this hypothesis. Given (37) that H3K9me0→1
is methylated faster than H3K9me1→2, one possible sce-
nario is that reduced levels of EHMT1 are enough to es-
tablish H3K9me1 but not to prevent the methylation to
H3K9me3 by other HMTs. Another plausible hypothesis
is that the excessive H3K9 methylation detected at post-
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Figure 6. Phenotyping (A) overview. (B) Circadian activity, actimetric cages. Locomotion is measured by the number of consecutive beam breaks (separated
by 7.5 cm). There are two beams in the cage (front and back). When the mouse go front, (break the front beam) then back (break the back beam), the
system records 1 unit.Ehmt1+/− mice display decreased locomotor activity and rears during the habitation phase. (C) Openfield,Ehtm1+/− display reduced
locomotory activity and rears. (D) The number of visits and number of rears in the social recognition test. (E) Duration of object exploration during
acquisition, and object recognition performance during retention. (F–G) Duration of immobility during habituation to the conditioning cage and during
context in the fear conditioning, and contextual freezing performance (*P < 0.05, **P < 0.01, ANOVA, Student–Newman–Keuls, §P < 0.05, one group
t-test, see Materials and Methods).
natal stages occurred at earlier development stages and is
subsequently maintained. Specifically, haploinsufficiency of
Ehmt1 could cause aberrant activity of other HMTs such as
Suv39H1/2 or SetDB1/2 in the dividing radial glia and/or
neuronal progenitors, which are abundant in embryonic
stage (38). Next, the replication machinery would main-
tain the aberrant H3K9 methylation up to the post-mitotic
cells of the postnatal brain (39). This scenario is consistent
with our findings in Ehmt1+/− hippocampus of increased
H3K9me3 already at P1 and stable postnatal epigenetic
deregulations.
Our work provides major advancements in the under-
standing of Ehmt1, Ehmt2 and their interplay in cognitive
disorders. Ehmt1 and Ehmt2 have been reported to work
as a heterodimeric complex (5,6). In line, deficiency of ei-
ther Ehmt1 or Ehmt2 has often been associated to similar
phenotypic/epigenetic outcomes (5,7–9,15,18). Conversely,
we find that haploinsufficiency of Ehmt2 has a considerably
lower epigenetic and behavioral impact than Ehmt1, indi-
cating the latter as more crucial in brain. Our result is com-
patible with a previous report showing that EHMT1, but
not EHMT2, is a limiting factor controlling the amount of
EHMT1/EHMT2 holoenzyme complex. Collectively, these
results may explain why patients with Ehmt2 genetic defects
have not yet been reported in ID/ASD population.
Interestingly, we also found several genes specifically
deregulated only in Ehmt1+/− or only in Ehmt2+/−. This
is in agreement with other recent findings suggesting that
Ehmt1 and Ehmt2, although being able to form het-
erodimers, may have functions independent of each other.
Specifically, (i) findings of functional differences between
Ehtm1 and Ehmt2, as for instance diverse binding affinity
towards histone substrates (32), (ii) different tissue-specific
expression profiles, as shown at the protein level in the audi-
tory brainstem and adipose tissue (40,41) and at the RNA
level in human tissue atlas (42) and (iii) markedly differ-
ent phenotypes ofEhmt1 andEhmt2mutants with impaired
ankyrin domains (17).
Interestingly, commonly repressed genes in both
Ehmt1+/− and Ehmt2+/− hippocampi include zinc finger
proteins, which were previously shown to be binding factors
recruiting EHMT1 and EHMT2 to the histone substrates
(7,43–45).
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Our epigenetic analysis disclosed the potential molecu-
lar mechanisms impaired in the Kleefstra syndrome. In-
terestingly Tdo2, an enzyme indirectly involved in sero-
tonin metabolism (46), is in our data up-regulated only in
Ehmt1+/− (2.2-fold H3K4me3, 1.7 RNA-seq plus changes
in H3K4me1, H3K27ac, H3K36me3, DNA methylation),
suggesting that serotonin deregulation could be one un-
derlying cause of the depressive/mood disorders we ob-
served in patients with Kleefstra syndrome (47). Also the
Protocadherins (Pcdhs), cell-adhesion molecules that con-
fer unique identities to individual neurons (30,31), appeared
extensively repressed specifically in Ehmt1+/− brain.
Recently, Pcdhs were shown to be stochastically ex-
pressed in single cells via differential DNA methylation at
individual promoters (48). Specifically, in aDnmt3b knock-
out model, impaired DNAmethylation was associated with
up-regulation of multiple alternative Pcdhs isoforms in sin-
gle neurons, with no detectable change in global (bulk)
brain levels. Our finding does not seem to be compatible
this scenario because we did not find significant changes in
DNA methylation of Pcdhs promoters. Furthermore, un-
like Toyoda and coworkers (48), we detect a global change
(reduction) of Pcdhs bulk expression. In addition to DNA
methylation, Pcdhs expression is also regulated by long
range interactions between enhancers and promoters medi-
ated by CTCF-cohesin (49,50). To date, several different en-
hancers have been found for Pcdhs alpha, beta and gamma
(48–51) and a model of a ‘transcriptional hub’ recruiting
promoters to enhancers has been proposed (49). Disruption
of interaction mechanisms by knocking out CTCF resulted
in a global reduction in Pcdhs bulk expression similar (al-
beit stronger) to ours (50). Furthermore, a targeted deletion
of DNase I hypersensitive (HS) site HS5–1, an enhancer
for the alpha cluster, caused a graded down-regulation of
Pcdhs (51) which resembles the graded patterns found in
Ehmt1+/-samples. Graded down-regulation may be due to
different binding affinities of the enhancers to the individ-
ual Pcdhs promoters, as shown for the alpha cluster (49).
Interestingly, the zinc finger proteinWiz, previously shown
to form a repressiveWiz/EHM1/EHMT2 tri-complex (45),
was recently found to localize at CTCF biding-sites and
to act as a transcriptional activator of Pcdhs. This could
explain how a decrease of EHMT1 can cause a down-
regulation of Pcdhs. In conclusion, we believe that our data
is compatible with an altered chromatin looping caused by
aberrant H3K9 methylation and impaired accessibility of
enhancers. Still, the nature of our data (bulk) prevents us to
draw exact conclusions about the deregulation of Pcdhs in
individual cells.
The main phenotype associated with Pcdhsmalfunction-
ing is a reduced dendritic arborization together with re-
duced mEPCSs (miniature excitatory postsynaptic poten-
tials) (30,31,50,52). Interestingly, the same phenotype was
found in Ehmt1+/− hippocampal neurons (11). Whether in
Ehmt1+/− brain the repression of Pcdhs is the effect and
not the cause of reduced dendritic arborization and synap-
tic changes is unlikely considering that Pcdhs appeared re-
pressed already at P1 stage, which is before the formation
of dendrites and synapses. At present, there is only one case
(53) of a syndrome in which gene expression analysis in a
mouse model has revealed a down-regulation of Pcdhs, the
Cornelia de Lange syndrome (developmental abnormali-
ties, intellectual disability, autistic-like behaviors) (54). It is
intriguing to speculate that both Kleefstra and Cornelia de
Lange syndromes could actually belong to a novel, broader
class of ID syndromes sharing malfunctioning of Pcdhs at
the molecular level.
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